FDA 483 - Ricola Ag - February 18, 2022

Ricola Ag, a pharmaceutical manufacturer, was cited for failing to thoroughly review unexplained discrepancies and batch failures during an FDA inspection. Specifically, 32 investigations into metal contamination over two years lacked identified root causes and corrective actions. This indicates a significant lapse in their quality management system.